Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Viscous Budesonide for Anastomotic Stricture in Esophageal Atresia
NCT03999008Unknown
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of EPI-EE in Anastomotic stricture and esophageal atresia (EA) (2 arms), sponsored by Centre Hospitalier Universitaire Sainte-Justine. Primary endpoint: Number of dilations needed after randomization at 12 months. Status: unknown.
02
Drugs
EPI-EE
03
Conditions
Anastomotic strictureesophageal atresia (EA)
Beyond the preview
Go deeper on NCT03999008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999008.